Message Center
{{ messageCount }} Messages
Watched Genes
{{$index + 1}}. {{ watchedObject.symbol }} (RGD ID:{{watchedObject.rgdId}})
Watched Ontology Terms
{{$index + 1}}. {{ watchedTerm.term }} ({{watchedTerm.accId}})
{{gene.symbol}}: {{ gene.description }}
Save what matters to you
{{ loginError }}
Sign in with your RGD account
x
Send Message
Gene: Olfml2a (olfactomedin-like 2A) Rattus norvegicus
Analyze
Symbol:
Olfml2a
Name:
olfactomedin-like 2A
RGD ID:
1311651
Description:
Predicted to enable extracellular matrix binding activity and identical protein binding activity. Predicted to be involved in signal transduction. Predicted to act upstream of or within extracellular matrix organization. Predicted to be located in extracellular matrix. Predicted to be active in extracellular space. Orthologous to human OLFML2A (olfactomedin like 2A); INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; all-trans-retinoic acid; bisphenol A.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
LOC296708; olfactomedin-like protein 2A
RGD Orthologs
Alliance Genes
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
OLFML2A (olfactomedin like 2A) HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, PhylomeDB, Treefam
Mus musculus (house mouse):
Olfml2a (olfactomedin-like 2A) HGNC
Treefam, EggNOG, OrthoMCL, NCBI, OMA, HomoloGene, Inparanoid, Panther, PhylomeDB, OrthoDB, Ensembl
Chinchilla lanigera (long-tailed chinchilla):
Olfml2a (olfactomedin like 2A) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
OLFML2A (olfactomedin like 2A) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
OLFML2A (olfactomedin like 2A) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Olfml2a (olfactomedin like 2A) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
OLFML2A (olfactomedin like 2A) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
OLFML2A (olfactomedin like 2A) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Olfml2a (olfactomedin like 2A) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Alliance orthologs 3
Homo sapiens (human):
OLFML2A (olfactomedin like 2A)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Mus musculus (house mouse):
Olfml2a (olfactomedin-like 2A)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
olfml2a (olfactomedin-like 2A)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Caenorhabditis elegans (roundworm):
F07A5.4
Alliance
DIOPT (InParanoid|OrthoFinder|PANTHER)
Caenorhabditis elegans (roundworm):
cof-2
Alliance
DIOPT (OrthoFinder|PANTHER|SonicParanoid)
Drosophila melanogaster (fruit fly):
CG6867
Alliance
DIOPT (OrthoFinder|PANTHER|SonicParanoid)
Caenorhabditis elegans (roundworm):
unc-122
Alliance
DIOPT (OrthoFinder|PANTHER|SonicParanoid)
Latest Assembly:
mRatBN7.2 - mRatBN7.2 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl mRatBN7.2 3 22,688,562 - 22,717,745 (+) NCBI mRatBN7.2 mRatBN7.2 Ensembl 3 22,688,598 - 22,717,909 (+) Ensembl Rnor_6.0 3 23,223,468 - 23,259,318 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 3 23,223,479 - 23,259,321 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 3 28,447,269 - 28,481,133 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 3 18,731,165 - 18,751,940 (+) NCBI RGSC3.4 rn4 RGSC3.4 RGSC_v3.1 3 18,615,477 - 18,644,690 (+) NCBI Celera 3 21,130,287 - 21,150,975 (+) NCBI Celera Cytogenetic Map 3 q12 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Imported Disease Annotations - CTD
Only show annotations with direct experimental evidence (0 objects hidden)
17beta-estradiol multiple interactions ISO RGD:1323220 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of OLFML2A mRNA CTD PMID:30165855 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of OLFML2A mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of OLFML2A mRNA CTD PMID:33387578 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1323220 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of OLFML2A mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol increases expression ISO RGD:1553798 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of OLFML2A mRNA CTD PMID:30951980 4-Chloro-ortho-phenylenediamine affects response to substance ISO RGD:1323220 6480464 OLFML2A gene SNP affects the susceptibility to 4-chloro-1, 2-diaminobenzene CTD PMID:25622337 aflatoxin B1 increases methylation ISO RGD:1323220 6480464 Aflatoxin B1 results in increased methylation of OLFML2A gene CTD PMID:28458013 all-trans-retinoic acid decreases expression ISO RGD:1323220 6480464 Tretinoin results in decreased expression of OLFML2A mRNA CTD PMID:21934132 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of OLFML2A mRNA CTD PMID:20488242 antirheumatic drug increases expression ISO RGD:1323220 6480464 Antirheumatic Agents results in increased expression of OLFML2A mRNA CTD PMID:24449571 arsenous acid increases expression ISO RGD:1323220 6480464 Arsenic Trioxide results in increased expression of OLFML2A mRNA CTD PMID:20458559 benzo[a]pyrene increases methylation ISO RGD:1323220 6480464 Benzo(a)pyrene results in increased methylation of OLFML2A promoter CTD PMID:27901495 benzo[a]pyrene decreases methylation ISO RGD:1323220 6480464 Benzo(a)pyrene results in decreased methylation of OLFML2A 3' UTR CTD PMID:27901495 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1323220 6480464 Diethylhexyl Phthalate results in increased expression of OLFML2A mRNA CTD PMID:31163220 bisphenol A increases expression ISO RGD:1323220 6480464 bisphenol A results in increased expression of OLFML2A mRNA CTD PMID:25047013 bisphenol A increases expression ISO RGD:1553798 6480464 bisphenol A results in increased expression of OLFML2A mRNA CTD PMID:30951980 bisphenol A multiple interactions ISO RGD:1323220 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of OLFML2A mRNA CTD PMID:28628672 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of OLFML2A mRNA CTD PMID:25181051 more ... bisphenol F increases expression ISO RGD:1553798 6480464 bisphenol F results in increased expression of OLFML2A mRNA CTD PMID:30951980 cadmium atom multiple interactions ISO RGD:1323220 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of OLFML2A mRNA CTD PMID:29741670 cadmium atom multiple interactions ISO RGD:1553798 6480464 [Tetradecanoylphorbol Acetate co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] affects the expression of OLFML2A mRNA CTD PMID:31904401 cadmium dichloride increases expression ISO RGD:1323220 6480464 Cadmium Chloride results in increased expression of OLFML2A mRNA CTD PMID:26472689 cadmium dichloride multiple interactions ISO RGD:1553798 6480464 [Tetradecanoylphorbol Acetate co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] affects the expression of OLFML2A mRNA CTD PMID:31904401 cadmium dichloride multiple interactions ISO RGD:1323220 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of OLFML2A mRNA CTD PMID:29741670 carbamazepine affects expression ISO RGD:1323220 6480464 Carbamazepine affects the expression of OLFML2A mRNA CTD PMID:25979313 chlordecone affects response to substance ISO RGD:1323220 6480464 OLFML2A gene SNP affects the susceptibility to Chlordecone CTD PMID:25622337 chlordecone increases expression ISO RGD:1553798 6480464 Chlordecone results in increased expression of OLFML2A mRNA CTD PMID:33711761 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of OLFML2A mRNA CTD PMID:24386269 CU-O LINKAGE decreases expression ISO RGD:1323220 6480464 cupric oxide results in decreased expression of OLFML2A mRNA CTD PMID:22077320 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of OLFML2A mRNA CTD PMID:26577399 decabromodiphenyl ether decreases expression EXP 6480464 decabromobiphenyl ether results in decreased expression of OLFML2A mRNA CTD PMID:23914054 dexamethasone multiple interactions ISO RGD:1323220 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of OLFML2A mRNA CTD PMID:28628672 diarsenic trioxide increases expression ISO RGD:1323220 6480464 Arsenic Trioxide results in increased expression of OLFML2A mRNA CTD PMID:20458559 dioxygen increases expression ISO RGD:1323220 6480464 Oxygen deficiency results in increased expression of OLFML2A mRNA CTD PMID:26516004 dorsomorphin multiple interactions ISO RGD:1323220 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression ISO RGD:1323220 6480464 Doxorubicin results in increased expression of OLFML2A mRNA CTD PMID:29803840 endosulfan affects expression EXP 6480464 Endosulfan affects the expression of OLFML2A mRNA CTD PMID:29391264 entinostat multiple interactions ISO RGD:1323220 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of OLFML2A mRNA CTD PMID:27188386 entinostat increases expression ISO RGD:1323220 6480464 entinostat results in increased expression of OLFML2A mRNA CTD PMID:26272509 , PMID:27188386 ethanol increases expression ISO RGD:1553798 6480464 Ethanol results in increased expression of OLFML2A mRNA CTD PMID:30319688 fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of OLFML2A mRNA CTD PMID:30307764 fonofos increases methylation ISO RGD:1323220 6480464 Fonofos results in increased methylation of OLFML2A promoter CTD PMID:22847954 formaldehyde increases expression ISO RGD:1323220 6480464 Formaldehyde results in increased expression of OLFML2A mRNA CTD PMID:28937961 furan increases expression EXP 6480464 furan results in increased expression of OLFML2A mRNA CTD PMID:27387713 genistein affects expression ISO RGD:1553798 6480464 Genistein affects the expression of OLFML2A mRNA CTD PMID:32186404 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of OLFML2A mRNA CTD PMID:33387578 indole-3-methanol multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of OLFML2A mRNA CTD PMID:22129741 indometacin multiple interactions ISO RGD:1323220 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of OLFML2A mRNA CTD PMID:28628672 methylseleninic acid increases expression ISO RGD:1323220 6480464 methylselenic acid results in increased expression of OLFML2A mRNA CTD PMID:18548127 N-nitrosodiethylamine increases expression ISO RGD:1323220 6480464 Diethylnitrosamine results in increased expression of OLFML2A mRNA CTD PMID:21527772 N-nitrosodiethylamine multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of OLFML2A mRNA CTD PMID:22129741 nickel atom decreases expression ISO RGD:1323220 6480464 Nickel results in decreased expression of OLFML2A mRNA CTD PMID:24768652 , PMID:25583101 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of OLFML2A mRNA CTD PMID:22110744 O-methyleugenol decreases expression ISO RGD:1323220 6480464 methyleugenol results in decreased expression of OLFML2A mRNA CTD PMID:32234424 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of OLFML2A mRNA CTD PMID:33387578 parathion increases methylation ISO RGD:1323220 6480464 Parathion results in increased methylation of OLFML2A promoter CTD PMID:22847954 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:1553798 6480464 [Tetradecanoylphorbol Acetate co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] affects the expression of OLFML2A mRNA CTD PMID:31904401 pirinixic acid increases expression ISO RGD:1553798 6480464 pirinixic acid results in increased expression of OLFML2A mRNA CTD PMID:20813756 raloxifene affects expression ISO RGD:1323220 6480464 Raloxifene Hydrochloride affects the expression of OLFML2A mRNA CTD PMID:14699072 SB 431542 multiple interactions ISO RGD:1323220 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:1323220 6480464 Silicon Dioxide analog results in decreased expression of OLFML2A mRNA, Silicon Dioxide results in decreased expression of OLFML2A mRNA CTD PMID:25351596 , PMID:25895662 sodium dodecyl sulfate decreases expression ISO RGD:1323220 6480464 Sodium Dodecyl Sulfate results in decreased expression of OLFML2A mRNA CTD PMID:31734321 sulforaphane decreases expression ISO RGD:1323220 6480464 sulforaphane results in decreased expression of OLFML2A mRNA CTD PMID:31838189 temozolomide decreases expression ISO RGD:1323220 6480464 Temozolomide results in decreased expression of OLFML2A mRNA CTD PMID:31758290 terbufos increases methylation ISO RGD:1323220 6480464 terbufos results in increased methylation of OLFML2A promoter CTD PMID:22847954 testosterone decreases expression ISO RGD:1323220 6480464 Testosterone results in decreased expression of OLFML2A mRNA CTD PMID:33359661 toluene increases expression EXP 6480464 Toluene results in increased expression of OLFML2A mRNA CTD PMID:22967744 trichostatin A increases expression ISO RGD:1323220 6480464 trichostatin A results in increased expression of OLFML2A mRNA CTD PMID:27188386 trimellitic anhydride decreases expression ISO RGD:1553798 6480464 trimellitic anhydride results in decreased expression of OLFML2A mRNA CTD PMID:19042947 triptonide increases expression ISO RGD:1553798 6480464 triptonide results in increased expression of OLFML2A mRNA CTD PMID:33045310 valproic acid affects expression ISO RGD:1323220 6480464 Valproic Acid affects the expression of OLFML2A mRNA CTD PMID:25979313 valproic acid increases methylation ISO RGD:1323220 6480464 Valproic Acid results in increased methylation of OLFML2A gene CTD PMID:29154799 valproic acid increases expression ISO RGD:1323220 6480464 Valproic Acid results in increased expression of OLFML2A mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO RGD:1323220 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of OLFML2A mRNA CTD PMID:27188386 vorinostat increases expression ISO RGD:1323220 6480464 vorinostat results in increased expression of OLFML2A mRNA CTD PMID:27188386
References
Additional References at PubMed
Genomics
QTLs in Region (mRatBN7.2)
70202 Alc19 Alcohol consumption QTL 19 2.5 drinking behavior trait (VT:0001422) ethanol intake volume to total fluid intake volume ratio (CMO:0001591) 3 1 27494778 Rat 631679 Cm10 Cardiac mass QTL 10 7.34 0.0001 heart left ventricle mass (VT:0007031) heart left ventricle weight to body weight ratio (CMO:0000530) 3 1 31158234 Rat 631831 Alc8 Alcohol consumption QTL 8 2.7 consumption behavior trait (VT:0002069) calculated ethanol drink intake rate (CMO:0001615) 3 1 33230976 Rat 61468 Bp15 Blood pressure QTL 15 4.4 blood pressure trait (VT:0000183) diastolic blood pressure (CMO:0000005) 3 1 33278763 Rat 61468 Bp15 Blood pressure QTL 15 4.4 blood pressure trait (VT:0000183) systolic blood pressure (CMO:0000004) 3 1 33278763 Rat 61468 Bp15 Blood pressure QTL 15 4.4 blood pressure trait (VT:0000183) pulse pressure (CMO:0000292) 3 1 33278763 Rat 631545 Bp85 Blood pressure QTL 85 3.1 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 3 1 33278763 Rat 4889966 Bss95 Bone structure and strength QTL 95 4.4 tibia area (VT:1000281) tibia-fibula cross-sectional area (CMO:0001718) 3 1 36847613 Rat 2312664 Scl62 Serum cholesterol level QTL 62 0.05 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 3 1 38710544 Rat 631568 Bp92 Blood pressure QTL 92 2.2 0.005 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 3 1 39874793 Rat 2290452 Scl56 Serum cholesterol level QTL 56 2.26 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 3 1 91609953 Rat 1298526 Arunc3 Aerobic running capacity QTL 3 2.2 exercise endurance trait (VT:0002332) maximum distance run on treadmill (CMO:0001406) 3 8227194 33703538 Rat 10401810 Kidm53 Kidney mass QTL 53 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 3 8227194 47233430 Rat 70203 Gcr2 Gastric cancer resistance QTL 2 2.6 stomach morphology trait (VT:0000470) stomach tumor susceptibility score (CMO:0002043) 3 8658162 27494778 Rat 1358357 Srcrtb1 Stress Responsive Cort Basal QTL 1 6.36 0.002 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 3 8658162 27494778 Rat 6893355 Bw101 Body weight QTL 101 0.4 0.38 body mass (VT:0001259) body weight (CMO:0000012) 3 10778704 30357018 Rat 6893363 Bw105 Body weight QTL 105 2.6 0.0036 body mass (VT:0001259) body weight (CMO:0000012) 3 10778704 30357018 Rat 1558654 Bw56 Body weight QTL 56 4.5 0.0000171 body mass (VT:0001259) body weight (CMO:0000012) 3 10778704 30357018 Rat 70191 BpQTLcluster4 Blood pressure QTL cluster 4 3 arterial blood pressure trait (VT:2000000) absolute change in mean arterial blood pressure (CMO:0000533) 3 10778704 50302886 Rat 70191 BpQTLcluster4 Blood pressure QTL cluster 4 3 arterial blood pressure trait (VT:2000000) absolute change in systolic blood pressure (CMO:0000607) 3 10778704 50302886 Rat 1558647 Cm46 Cardiac mass QTL 46 5.4 0.0000055 heart mass (VT:0007028) heart wet weight (CMO:0000069) 3 10778823 30356773 Rat 1558650 Cm48 Cardiac mass QTL 48 4 0.0001 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 3 10778823 30356773 Rat 1558657 Cm43 Cardiac mass QTL 43 6.6 0.0000000293 heart mass (VT:0007028) heart wet weight (CMO:0000069) 3 10778823 30356773 Rat 1358905 Hrtrt17 Heart rate QTL 17 5.9 0.000014 heart pumping trait (VT:2000009) heart rate (CMO:0000002) 3 10861912 89878372 Rat 1358885 Bp251 Blood pressure QTL 251 3.8 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 3 14489145 121056321 Rat 1358888 Bp264 Blood pressure QTL 264 4.43 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 3 14489145 121056321 Rat 2298542 Neuinf11 Neuroinflammation QTL 11 3.9 nervous system integrity trait (VT:0010566) spinal cord complement component 1, q subcomponent, B chain mRNA level (CMO:0002126) 3 15005422 76927699 Rat 631676 Cm8 Cardiac mass QTL 8 7.03 0.0001 aorta mass (VT:0002845) aorta weight (CMO:0000076) 3 16954708 61954708 Rat 634306 Bp140 Blood pressure QTL 140 3.3 0.0013 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 3 17374703 35528639 Rat 634306 Bp140 Blood pressure QTL 140 3.3 0.0013 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 3 17374703 35528639 Rat 634306 Bp140 Blood pressure QTL 140 3.3 0.0013 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 3 17374703 35528639 Rat 634306 Bp140 Blood pressure QTL 140 3.3 0.0013 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 3 17374703 35528639 Rat 634306 Bp140 Blood pressure QTL 140 3.3 0.0013 arterial blood pressure trait (VT:2000000) heart rate (CMO:0000002) 3 17374703 35528639 Rat 634306 Bp140 Blood pressure QTL 140 3.3 0.0013 arterial blood pressure trait (VT:2000000) heart rate (CMO:0000002) 3 17374703 35528639 Rat 634306 Bp140 Blood pressure QTL 140 3.3 0.0013 arterial blood pressure trait (VT:2000000) body weight (CMO:0000012) 3 17374703 35528639 Rat 634306 Bp140 Blood pressure QTL 140 3.3 0.0013 arterial blood pressure trait (VT:2000000) body weight (CMO:0000012) 3 17374703 35528639 Rat 2325840 Bp345 Blood pressure QTL 345 0.001 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 3 18311454 28441896 Rat 731172 Bp151 Blood pressure QTL 151 0.04 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 3 18311454 47233430 Rat 12879849 Bw180 Body weight QTL 180 0.037 body mass (VT:0001259) body weight (CMO:0000012) 3 18311454 47233430 Rat 12879850 Cm91 Cardiac mass QTL 91 0.001 heart mass (VT:0007028) heart wet weight to body weight ratio (CMO:0002408) 3 18311454 47233430 Rat 12879851 Cm92 Cardiac mass QTL 92 0.001 heart left ventricle mass (VT:0007031) heart left ventricle weight to body weight ratio (CMO:0000530) 3 18311454 47233430 Rat 12879852 Cm93 Cardiac mass QTL 93 0.001 heart right ventricle mass (VT:0007033) heart right ventricle weight to body weight ratio (CMO:0000914) 3 18311454 47233430 Rat 12879853 Am5 Aortic mass QTL 5 0.001 aorta mass (VT:0002845) aorta weight to aorta length to body weight ratio (CMO:0002722) 3 18311454 47233430 Rat 12879854 Kidm63 Kidney mass QTL 63 0.001 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 3 18311454 47233430 Rat 10450804 Scl70 Serum cholesterol level QTL 70 4.7 0.001 blood LDL cholesterol amount (VT:0000181) blood low density lipoprotein cholesterol level (CMO:0000053) 3 20714090 65714090 Rat 10450794 Scl69 Serum cholesterol level QTL 69 6.3 0.001 blood LDL cholesterol amount (VT:0000181) blood low density lipoprotein cholesterol level (CMO:0000053) 3 20714090 65714090 Rat
